newmedsupplies.com: DMEMEDS shared post via Reuters: AcelRx stock plunges after FDA rejects pain drug device

Tuesday, August 12, 2014

DMEMEDS shared post via Reuters: AcelRx stock plunges after FDA rejects pain drug device

(Reuters) - Shares of AcelRx Pharmaceuticals Inc plunged nearly 28 percent in premarket trading, after the U.S. Food and Drug Administration rejected its pain drug device, Zalviso, late on Friday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/SUVK-g_tSco/story01.htm

Read More

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)